Clinical trials
Burkitt Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 8 |
| National Cancer Institute (NCI) | 8 |
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| Baxalta now part of Shire | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Imugene Limited | 1 |
| Merck Sharp & Dohme LLC | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 28 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Lymphoma | 9 |
| Leukemia | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Dendritic Cell Sarcoma, Interdigitating | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Recurrence | 4 |
| Hodgkin Disease | 3 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.